AlphaPai raises $50M Series B for AI investment research tools

AlphaPai, an AI investment-research assistant built by Rabyte Technology (讯兔科技) for professional investors, said it closed a US$50 million Series B — its third financing round in the past year. Strategic backers named in the company release include China Insurance Investment and GF Xinde Investment Management, with Qiming Venture Partners, Ambrum Capital, Next Capital, Trustar Capital, and Eastern Bell Capital also participating; China Renaissance was exclusive financial advisor.

Same-day primary capital is going into software professional investors use before they buy or sell. Insurance and securities-linked backers on this Series B point to demand for AI inside research desks — not another lab-pacing echo.

AlphaPai, an AI investment-research assistant developed by financial AI company Rabyte Technology (讯兔科技) for professional investors, announced via PR Newswire Asia on 15 Sep 2026 that it completed a Series B of US$50 million. Series B is mid-stage funding — a growth round after seed money and Series A, not a first check. The company said this is its third consecutive financing round in the past year. That company release, dated Hong Kong, Sept. 15, 2026, 13:10 +08, is the filing event. These are company claims. This desk did not see the term sheet.

What the product is, as the company describes it: software that helps professional investors do investment research — the analyst and portfolio-manager work that happens before a buy or sell, such as reading filings, comparing companies, and writing notes. An AI workstation is software for those workflows, not a human financial adviser. File that picture as AlphaPai’s. This desk did not run the product, and this is not investment advice.

Named participants, as the release lists them: China Insurance Investment, described as the national investment platform for China’s insurance industry; GF Xinde Investment Management, the private-equity arm of GF Securities; plus Qiming Venture Partners, Ambrum Capital, Next Capital, Trustar Capital, and Eastern Bell Capital, alongside existing shareholders. China Renaissance continued as exclusive financial advisor. File the roster as AlphaPai’s. This desk is not inventing a valuation, an ownership percentage, or a check size. None was printed beyond the US$50 million total. The English company PR states US$50 million — this desk is not converting a Chinese RMB headline as fact.

Use of proceeds, as the company tells it: increase research and development in models and products; expand its multi-asset client base — more than one asset class, such as stocks and bonds; deepen industry collaboration; cultivate its home market; and advance an overseas footprint. File the spend plan as AlphaPai’s. This desk did not audit payroll.

Scale, as the same release has it: more than 120,000 professional users across over 8,000 financial institutions and asset managers. File those counts as the company’s. This desk did not verify the user or institution numbers, and it is not repeating a global-rank claim.

Product timeline, still the company’s: PaiWork, an AI investment-research workstation, launched in April 2026. The company says it brings financial data, research tools, productivity software, and knowledge bases into one working environment. In June 2026 it introduced iRaB — Investment Research Agent Benchmark, a test of how AI handles real research tasks — and the ORE, or Open Research Ecosystem, partner program, with more than 40 brokerage research institutes and data providers. File the dates, the names, and the 40-plus partner count as AlphaPai’s. This desk did not sit in those launches.

Luodan Li, founder and chief executive, is named on the release. File the name and title as the company’s. His quotes are color only and stay in Sources. This desk is not inventing other executive names.

PRIMARY here: AlphaPai / Rabyte via PR Newswire Asia, 15 Sep 2026 — Tier A company source, the originating English release. The company site is product-home context, not a second originating newsroom. The US$50 million figure, the third-round-in-a-year claim, the named backers, the 120,000 / 8,000 scale figures, and the PaiWork / iRaB / ORE dates are company-attributed. NOT claimed: a valuation, ownership percentages, revenue, independently verified user or institution counts, a global ranking, a Chinese-yuan conversion of the headline, that this desk tested PaiWork, a stock tip, or investment advice. Distinct from the already-filed flam-40m-series-b, nuance-labs-50m, euclyd-200m-series-a, exein-270m-physical-ai, temporal-550m-series-e, tandem-health-100m-series-b, cornelis-205m-active-compute-fabric, hanwha-plus-korea-hbm-ai-etfs, and anthropic-claude-financial-advisors.